明達醫（6527）股票可以買嗎？K線圖AI分析回答目標合理價
K線圖與股價本日交易資訊
資料日期：
，每天14:00後更新。
本日股價資訊
| 開 |
高 |
低 |
收 |
| 81.8 |
81.8 |
80.8 |
80.9 |
查看每日股價資訊表格
每日股價資訊
| 日期 |
開盤價 |
最高價 |
最低價 |
收盤價 |
成交量 |
| 2025/05/07 |
80.7 |
80.7 |
80.5 |
80.5 |
6 |
| 2025/05/08 |
80.8 |
82.9 |
80.8 |
82.9 |
10 |
| 2025/05/09 |
81 |
81 |
81 |
81 |
6 |
| 2025/05/12 |
81.1 |
82.6 |
81.1 |
82.1 |
21 |
| 2025/05/13 |
83.8 |
83.8 |
81.9 |
81.9 |
7 |
| 2025/05/14 |
81.7 |
81.8 |
81.1 |
81.3 |
31 |
| 2025/05/15 |
81.3 |
82.2 |
81 |
82.2 |
15 |
| 2025/05/16 |
82.2 |
82.2 |
82.2 |
82.2 |
29 |
| 2025/05/19 |
82.6 |
83 |
82 |
82.3 |
36 |
| 2025/05/20 |
82 |
82.2 |
82 |
82.1 |
23 |
| 2025/05/21 |
82 |
83 |
82 |
83 |
33 |
| 2025/05/22 |
82.5 |
83.5 |
82.5 |
83.3 |
24 |
| 2025/05/23 |
83.3 |
83.5 |
83.3 |
83.5 |
16 |
| 2025/05/26 |
84.2 |
84.2 |
82.5 |
82.6 |
55 |
| 2025/05/27 |
83.7 |
85 |
83.6 |
84.6 |
55 |
| 2025/05/28 |
84.7 |
84.7 |
84 |
84.3 |
39 |
| 2025/05/29 |
83.4 |
84.4 |
83.4 |
83.8 |
8 |
| 2025/06/02 |
83.5 |
83.5 |
83 |
83.5 |
14 |
| 2025/06/03 |
84 |
84 |
83.5 |
84 |
17 |
| 2025/06/04 |
84 |
84.2 |
84 |
84.2 |
17 |
| 2025/06/05 |
84.2 |
84.2 |
84.2 |
84.2 |
6 |
| 2025/06/06 |
84.4 |
84.6 |
84.2 |
84.6 |
18 |
| 2025/06/09 |
91.3 |
93 |
90.7 |
91.6 |
3,329 |
| 2025/06/10 |
89 |
90 |
86.3 |
88.2 |
284 |
| 2025/06/11 |
88.2 |
89.9 |
87.3 |
87.3 |
71 |
| 2025/06/12 |
88.8 |
88.8 |
86.8 |
88.5 |
110 |
| 2025/06/13 |
88.8 |
88.8 |
87.4 |
88.5 |
29 |
| 2025/06/16 |
88.5 |
89.6 |
87.6 |
87.7 |
80 |
| 2025/06/17 |
86.6 |
87.7 |
86 |
86.5 |
25 |
| 2025/06/18 |
86.5 |
86.8 |
86.5 |
86.8 |
22 |
| 2025/06/19 |
88 |
88.3 |
87.8 |
88.3 |
61 |
| 2025/06/23 |
87.9 |
88.7 |
87.9 |
88.7 |
42 |
| 2025/06/24 |
89.3 |
89.3 |
87.3 |
88.8 |
79 |
| 2025/06/25 |
88.7 |
88.7 |
88.2 |
88.6 |
13 |
| 2025/06/26 |
87.8 |
87.8 |
87 |
87.1 |
36 |
| 2025/06/27 |
87.1 |
87.3 |
87 |
87.3 |
13 |
| 2025/06/30 |
87.8 |
87.8 |
86 |
87 |
129 |
| 2025/07/01 |
87.3 |
87.3 |
86.5 |
87 |
19 |
| 2025/07/02 |
87 |
87 |
87 |
87 |
7 |
| 2025/07/03 |
87.9 |
87.9 |
86.7 |
86.7 |
24 |
| 2025/07/04 |
86.3 |
86.7 |
85.8 |
86.7 |
80 |
| 2025/07/07 |
86 |
86 |
85.6 |
85.6 |
8 |
| 2025/07/08 |
85.1 |
85.7 |
85 |
85.2 |
13 |
| 2025/07/09 |
81.9 |
85.5 |
81.9 |
85.5 |
32 |
| 2025/07/10 |
86 |
87 |
86 |
87 |
32 |
| 2025/07/11 |
87.8 |
87.8 |
87 |
87 |
3 |
| 2025/07/14 |
87 |
87 |
87 |
87 |
43 |
| 2025/07/15 |
86 |
87 |
85.9 |
87 |
56 |
| 2025/07/16 |
86.1 |
86.6 |
86.1 |
86.3 |
7 |
| 2025/07/17 |
86.3 |
86.3 |
85.8 |
85.8 |
78 |
| 2025/07/18 |
86.3 |
86.7 |
86 |
86.7 |
30 |
| 2025/07/21 |
86.5 |
86.5 |
86 |
86.5 |
15 |
| 2025/07/22 |
86.7 |
86.7 |
85.9 |
86.5 |
25 |
| 2025/07/23 |
86.5 |
88.6 |
86.5 |
88.6 |
64 |
| 2025/07/24 |
86.9 |
87.5 |
86.9 |
87.2 |
35 |
| 2025/07/25 |
87.5 |
87.6 |
87.2 |
87.3 |
25 |
| 2025/07/28 |
87 |
87.3 |
87 |
87.1 |
50 |
| 2025/07/29 |
87 |
87 |
86.5 |
87 |
38 |
| 2025/07/30 |
87 |
87 |
84.8 |
86.9 |
9 |
| 2025/07/31 |
85.3 |
85.3 |
85.3 |
85.3 |
5 |
| 2025/08/01 |
85 |
85.9 |
85 |
85.9 |
17 |
| 2025/08/04 |
86.3 |
86.3 |
85.5 |
85.6 |
9 |
| 2025/08/05 |
86.8 |
87.2 |
86 |
86.1 |
38 |
| 2025/08/06 |
86.1 |
87 |
86.1 |
86.4 |
38 |
| 2025/08/07 |
88 |
88 |
86.4 |
86.9 |
41 |
| 2025/08/08 |
86.3 |
86.9 |
86.1 |
86.9 |
26 |
| 2025/08/11 |
85.8 |
85.8 |
84.1 |
84.9 |
173 |
| 2025/08/12 |
84.9 |
86.4 |
84.8 |
86 |
24 |
| 2025/08/13 |
86 |
87 |
86 |
86 |
30 |
| 2025/08/14 |
87 |
87.2 |
86.5 |
87.2 |
35 |
| 2025/08/15 |
87 |
87.2 |
86.5 |
87.1 |
23 |
| 2025/08/18 |
87 |
87.5 |
87 |
87.5 |
169 |
| 2025/08/19 |
87.2 |
87.2 |
86.6 |
86.7 |
23 |
| 2025/08/20 |
86.5 |
86.5 |
86.3 |
86.4 |
11 |
| 2025/08/21 |
86.4 |
87.1 |
86.4 |
87.1 |
16 |
| 2025/08/22 |
86.6 |
87 |
86.6 |
86.9 |
25 |
| 2025/08/25 |
87.1 |
87.1 |
85 |
86 |
54 |
| 2025/08/26 |
86 |
86 |
86 |
86 |
21 |
| 2025/08/27 |
86.1 |
87.5 |
86 |
87.5 |
69 |
| 2025/08/28 |
87.4 |
87.5 |
87 |
87 |
35 |
| 2025/08/29 |
87 |
87.1 |
86.4 |
86.4 |
48 |
| 2025/09/01 |
87 |
87 |
86.6 |
87 |
42 |
| 2025/09/02 |
86.7 |
88 |
86.7 |
88 |
81 |
| 2025/09/03 |
88 |
88.2 |
88 |
88 |
29 |
| 2025/09/04 |
87.7 |
90.8 |
87.1 |
88.8 |
42 |
| 2025/09/05 |
88.5 |
89.4 |
88.5 |
88.6 |
29 |
| 2025/09/08 |
88.7 |
88.8 |
87.6 |
87.9 |
35 |
| 2025/09/09 |
87.6 |
88 |
86.9 |
88 |
19 |
| 2025/09/10 |
87.8 |
88.2 |
87.1 |
87.1 |
205 |
| 2025/09/11 |
87 |
87 |
86.6 |
86.6 |
12 |
| 2025/09/12 |
86.5 |
86.5 |
86 |
86.5 |
21 |
| 2025/09/15 |
86.2 |
86.2 |
86.1 |
86.1 |
7 |
| 2025/09/16 |
87.5 |
87.5 |
86 |
86 |
19 |
| 2025/09/17 |
85 |
86.1 |
85 |
86 |
107 |
| 2025/09/18 |
86 |
86.1 |
85.5 |
85.6 |
77 |
| 2025/09/19 |
85.8 |
86.5 |
85.8 |
86.5 |
13 |
| 2025/09/22 |
86.1 |
86.3 |
86 |
86.1 |
24 |
| 2025/09/23 |
85.6 |
86 |
85.3 |
86 |
8 |
| 2025/09/25 |
85.7 |
87.3 |
85.7 |
87.3 |
37 |
| 2025/09/26 |
86.3 |
86.4 |
86.1 |
86.1 |
8 |
| 2025/09/30 |
86 |
86 |
85.8 |
85.8 |
18 |
| 2025/10/01 |
85.3 |
85.5 |
85.3 |
85.5 |
5 |
| 2025/10/02 |
85.8 |
85.9 |
85.7 |
85.7 |
12 |
| 2025/10/03 |
85.3 |
86 |
85.3 |
86 |
15 |
| 2025/10/07 |
86 |
86 |
85.7 |
85.7 |
6 |
| 2025/10/08 |
85.2 |
86 |
85.2 |
86 |
25 |
| 2025/10/09 |
86 |
86.1 |
85.6 |
86.1 |
19 |
| 2025/10/13 |
85.2 |
86.1 |
84.6 |
85.2 |
16 |
| 2025/10/14 |
86.1 |
86.2 |
84.6 |
84.6 |
260 |
| 2025/10/15 |
84.6 |
85.1 |
84.6 |
85.1 |
40 |
| 2025/10/16 |
85 |
85 |
85 |
85 |
10 |
| 2025/10/17 |
83.8 |
84.3 |
83.5 |
83.9 |
261 |
| 2025/10/20 |
83.8 |
84 |
83.5 |
83.5 |
25 |
| 2025/10/21 |
83.5 |
83.5 |
83 |
83.5 |
167 |
| 2025/10/22 |
83.2 |
83.6 |
83.2 |
83.6 |
12 |
| 2025/10/23 |
83.2 |
83.6 |
83.2 |
83.2 |
20 |
| 2025/10/27 |
83.2 |
83.3 |
83 |
83.1 |
87 |
| 2025/10/28 |
83 |
83 |
82.6 |
82.6 |
11 |
| 2025/10/29 |
82.9 |
82.9 |
81.7 |
81.7 |
40 |
| 2025/10/30 |
81.8 |
81.8 |
80.8 |
80.9 |
126 |
AI的K線圖分析和操作建議
以下內容由AI生成：
點擊查看。AI建議自動產生於：，輸入：市場模型。
明達醫 (6527) 股價走勢分析與操作建議
未來趨勢判斷…
明達醫 (6527) 股價走勢分析與操作建議
未來趨勢判斷與理由
根據提供的 90 天 K 線圖，明達醫 (6527) 在最近的交易時段呈現明顯的下跌趨勢。自 2025 年 9 月以來，股價持續走弱，並已跌破了 5 日移動平均線 (MA5) 和 20 日移動平均線 (MA20)。特別是在 2025 年 10 月下旬，股價連續出現綠色 K 線（代表下跌），顯示賣壓沉重。MA5 已明顯向下穿越 MA20，形成死亡交叉，這是一個重要的看跌技術指標。成交量柱狀圖在近期並未出現異常放大以支撐反彈，反而呈現萎縮跡象， indicative of a lack of buying interest. 綜合以上技術指標，預計未來數天至數週，明達醫的股價將持續處於下跌或盤整格局，短期內難見強勁反彈。
未來目標價格區間
考量到當前股價已跌破 MA20，且趨勢向下，預計短期內股價可能測試前期的低點。從圖表上觀察，在 2025 年 5 月下旬，股價曾在約 81 元附近獲得支撐。因此，可以預期未來股價可能向下探測至 80 元至 82 元的區間。若跌破此區間，則可能進一步下探至 78 元或更低。
操作建議 (針對散戶投資人)
針對「明達醫 (6527) 可以買嗎」的疑問，基於目前的技術分析，**目前不建議散戶投資人在此時買進**。
以下是具體的操作建議：
* **避免追高買入：** 鑑於當前股價處於下跌趨勢，不應在反彈時追高買入，以免陷入套牢的風險。
* **謹慎伺機放空：** 對於有經驗且風險承受能力較高的散戶，若能有效控制風險，可考慮在反彈至壓力區（例如 MA20 附近，約 85-86 元）時，伺機進行短線放空操作。但此操作風險極高，需嚴設停損。
* **等待止跌訊號：** 建議散戶投資人應耐心等待股價出現止跌跡象，例如出現連續性的綠色 K 線縮短、出現長下影線、或出現價量配合的初步止跌訊號。同時，觀察 MA5 是否能再次上彎並穿越 MA20，形成黃金交叉，這將是較為穩健的買進訊號。
* **關注基本面：** 技術分析僅為其中一個面向，建議散戶投資人應同時關注明達醫的基本面資訊，包括公司營收、獲利能力、產業前景等，綜合判斷公司長期的價值。若基本面有明顯改善，即使技術面短期偏空，長線仍有機會。
* **設定停損點：** 無論任何操作，務必設定明確的停損點，並嚴格執行，以控制潛在的虧損。
總結與重申
總結而言，基於 2025 年 10 月 29 日的 K 線圖，明達醫 (6527) 目前呈現明顯的下跌趨勢。MA5 已跌破 MA20，且股價持續走低，預計短期內將延續此趨勢。
* **趨勢預測：** 下跌或盤整。
* **目標價格區間：** 短期內預計測試 80 元至 82 元區間，若持續下跌，可能下探至 78 元。
對於散戶投資人而言，目前並非買進的合適時機。建議待出現明確的止跌訊號，或基本面有顯著好轉後再行考慮。
| 股票代碼 |
股票名稱 |
圖表類型 |
分析日期 |
| 6527 |
明達醫 |
近 90 天 K 線圖 |
2025-10-29 |
股權分散表
查看每日股權分散表表格
每週股權分散表分級資料
| 日期 |
100張以下持股比例 |
100~1000張持股比例 |
1000張以上持股比例 |
總股東人數 |
| 2024/09/20 |
37.6% |
39.61% |
22.72% |
3,086 |
| 2024/09/27 |
37.68% |
43.02% |
19.22% |
3,036 |
| 2024/10/04 |
37.74% |
42.95% |
19.23% |
3,022 |
| 2024/10/11 |
37.25% |
43.35% |
19.34% |
3,006 |
| 2024/10/18 |
37.05% |
43.44% |
19.43% |
2,978 |
| 2024/10/25 |
36.84% |
43.57% |
19.52% |
2,960 |
| 2024/11/01 |
36.76% |
43.65% |
19.52% |
2,949 |
| 2024/11/08 |
36.71% |
43.66% |
19.56% |
2,932 |
| 2024/11/15 |
36.53% |
43.65% |
19.75% |
2,901 |
| 2024/11/22 |
36.42% |
43.65% |
19.85% |
2,886 |
| 2024/11/29 |
36.26% |
43.66% |
20.01% |
2,868 |
| 2024/12/06 |
36.26% |
43.67% |
20.01% |
2,861 |
| 2024/12/13 |
36.25% |
43.69% |
20.01% |
2,852 |
| 2024/12/20 |
36.18% |
43.75% |
20.01% |
2,844 |
| 2024/12/27 |
36.17% |
43.76% |
20.01% |
2,834 |
| 2025/01/03 |
36.16% |
43.76% |
20.01% |
2,832 |
| 2025/01/10 |
36.09% |
43.76% |
20.08% |
2,826 |
| 2025/01/17 |
35.94% |
43.78% |
20.2% |
2,823 |
| 2025/01/22 |
35.86% |
43.79% |
20.28% |
2,812 |
| 2025/02/07 |
35.88% |
43.78% |
20.28% |
2,808 |
| 2025/02/14 |
35.86% |
43.79% |
20.28% |
2,801 |
| 2025/02/21 |
35.5% |
44.14% |
20.28% |
2,885 |
| 2025/02/27 |
35.51% |
44.15% |
20.28% |
2,866 |
| 2025/03/07 |
35.38% |
44.15% |
20.39% |
2,858 |
| 2025/03/14 |
35.34% |
44.2% |
20.39% |
2,843 |
| 2025/03/21 |
35.34% |
44.21% |
20.39% |
2,844 |
| 2025/03/28 |
34.63% |
44.92% |
20.39% |
2,843 |
| 2025/04/02 |
34.56% |
44.98% |
20.39% |
2,826 |
| 2025/04/11 |
34.75% |
44.43% |
20.77% |
2,804 |
| 2025/04/18 |
34.98% |
44.07% |
20.86% |
2,787 |
| 2025/04/25 |
34.94% |
44.05% |
20.93% |
2,787 |
| 2025/05/02 |
34.91% |
44.05% |
20.93% |
2,775 |
| 2025/05/09 |
34.91% |
44.04% |
20.97% |
2,774 |
| 2025/05/16 |
34.84% |
44.04% |
21.04% |
2,762 |
| 2025/05/23 |
34.74% |
43.43% |
21.76% |
2,758 |
| 2025/05/29 |
34.95% |
42.96% |
22% |
2,747 |
| 2025/06/06 |
34.84% |
42.96% |
22.11% |
2,739 |
| 2025/06/13 |
35.33% |
42.46% |
22.14% |
2,747 |
| 2025/06/20 |
35.18% |
42.45% |
22.29% |
2,731 |
| 2025/06/27 |
35.02% |
42.43% |
22.48% |
2,714 |
| 2025/07/04 |
34.64% |
42.39% |
22.88% |
2,702 |
| 2025/07/11 |
34.61% |
42.37% |
22.97% |
2,684 |
| 2025/07/18 |
34.94% |
41.97% |
23.02% |
2,681 |
| 2025/07/25 |
34.47% |
41.96% |
23.5% |
2,661 |
| 2025/08/01 |
34.36% |
41.94% |
23.63% |
2,673 |
| 2025/08/08 |
33.95% |
42.33% |
23.63% |
2,661 |
| 2025/08/15 |
33.76% |
42.34% |
23.82% |
2,624 |
| 2025/08/22 |
33.57% |
42.32% |
24.05% |
2,611 |
| 2025/08/29 |
33.32% |
42.25% |
24.36% |
2,587 |
| 2025/09/05 |
33.24% |
42.2% |
24.49% |
2,582 |
| 2025/09/12 |
33.1% |
42.14% |
24.69% |
2,565 |
| 2025/09/19 |
33.03% |
41.75% |
25.14% |
2,565 |
| 2025/09/26 |
32.93% |
41.69% |
25.33% |
2,554 |
| 2025/10/03 |
32.92% |
41.67% |
25.33% |
2,544 |
| 2025/10/09 |
32.87% |
41.64% |
25.42% |
2,537 |
| 2025/10/17 |
32.8% |
41.58% |
25.54% |
2,517 |
| 2025/10/23 |
32.77% |
41.61% |
25.54% |
2,497 |
評論討論區
發表評論
目前尚無評論